-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Pear Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2022.
- Pear Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2022 was $3.68M, a 99.6% increase year-over-year.
- Pear Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2022 was $13.5M, a 255% increase year-over-year.
- Pear Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $13.5M, a 255% increase from 2021.
- Pear Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $3.81M, a 57.8% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)